#United States #New York #securities lawsuit #Faruqi & Faruqi #POMDOCTOR

Pomdoctor Investors Take Note: Important Class Action Information

In a crucial reminder for investors, Faruqi & Faruqi, LLP, a prominent national securities law firm, is calling on individuals who invested in Pomdoctor Limited between October 9, 2025, and December 11, 2025, to be aware of a pressing deadline in the federal securities class action. This deadline is set for April 13, 2026, and it's important for those who have suffered losses during this period to understand their rights and avenues for potential recovery.

The firm is currently investigating allegations against Pomdoctor, known by its NASDAQ ticker POM, regarding various violations of federal securities laws. Namely, the investigation centers around purported misleading statements made by the company's executives and the suppression of crucial information that may have affected investors' decisions. This class action follows disturbances in Pomdoctor’s stock prices, where significant declines were observed amidst allegations of a fraudulent stock promotion scheme and unaddressed social media misinformation.

Details of the Allegations

The complaint outlines several serious claims against Pomdoctor and its leadership:
1. Fraudulent Stock Promotion Scheme: It is alleged that Pomdoctor was involved in a scheme that misled investors through manipulated social media narratives, wherein false financial professionals were impersonated.
2. Insider Trading Activities: Claims suggest that certain insiders and affiliates utilized offshore accounts to systematically dump shares during a heightened price inflation period.
3. Omissions of Risk Disclosures: The company's announcements reportedly did not adequately inform investors of the misleading rumors and the unusual trading activities that were artificially inflating stock prices.
4. Misleading Statements: Given the aforementioned activities, the statements released by Pomdoctor regarding its business operations and prospects were deemed materially misleading or baseless.

As these allegations came to light, Pomdoctor’s stock suffered a drastic drop, closing at approximately $0.50 on December 10, 2025, before plummeting to $0.38 just a day later, equating to a 24% decline in value during a single trading session. This downturn follows a period marked by significant volatility that raised concerns amongst the investor community about Pomdoctor's fiscal health and stock valuation.

Call to Action for Investors

Faruqi & Faruqi emphasizes the importance of acting quickly, as the firm encourages all potential class members to consider stepping forward to join the action to reclaim their financial losses. The appointed lead plaintiff will be the individual with the most substantial stake in the case, whom the court deems adequate and representative of the class. However, it is vital to note that all class members will have rights to any recovery regardless of whether they choose to serve as a lead plaintiff.

Additionally, the firm urges anyone who possesses further information concerning Pomdoctor's alleged conduct to come forward. This includes insights from whistleblowers, former employees, shareholders, and more.

To learn more about this unfolding court case, investors can visit Faruqi & Faruqi’s dedicated Pomdoctor page or reach out directly to Josh Wilson, a partner at the firm, via phone at 877-247-4292 or 212-983-9330, extension 1310.

With the deadline looming, understanding your rights as an investor is more critical than ever. The legal landscape can be daunting, but with the guidance of a seasoned firm like Faruqi & Faruqi, investors can navigate these waters with greater confidence.

Stay informed on updates related to the Pomdoctor case and other significant developments in securities law by connecting with Faruqi & Faruqi on LinkedIn, X, and Facebook.

• ---

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP. Earlier outcomes do not guarantee similar results in future cases.